You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Identifying Patients With Progressive Fibrosing Interstitial Lung Diseases

  • Authors: Athol Wells, MD; Christopher P. Denton, PhD, FRCP
  • CPD Released: 11/19/2018
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 11/19/2019, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US pulmonologists, rheumatologists, allergists, and clinical immunologists.

The goal of this activity is to improve physician knowledge regarding the identification of patients with a progressive fibrosing phenotype and potential therapeutic options, including antifibrotic treatment, for patients with progressive fibrosing interstitial lung diseases (PF-ILDs).

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Characteristics of patients with a PF-ILD phenotype
  • Have greater competence related to
    • Establishing differential diagnoses of diverse ILD profiles that are likely to show progressive fibrosis, based on patient case examples
  • Demonstrate greater confidence in their ability to
    • Evaluate available information on antifibrotic therapy for patients with PF-ILDs


Faculty

  • Athol Wells, MD

    Professor
    Interstitial Lung Disease Unit
    Royal Brompton and Harefield NHS Foundation Trust
    London, United Kingdom

    Disclosures

    Disclosure: Athol Wells, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Roche Holding AG
    Served as a speaker or a member of a speakers bureau for: Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Roche Holding AG

  • Christopher R. Denton, PhD, FRCP

    Professor
    Royal Free Hospital and University College London
    London, United Kingdom

    Disclosures

    Disclosure: Christopher R. Denton, PhD, FRCP, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Actelion Pharmaceuticals, Ltd; Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Corbus Pharmaceuticals; Inventiva Pharma; Roche Holdings AG; Sanofi Aventis
    Received grants for clinical research from: CSL Behring; GlaxoSmithKline; Inventiva Pharma; Roche Holdings AG

Editor

  • Marinella Calle, PhD, CMPP

    Scientific Director, WebMD Global, LLC

    Disclosures

    Disclosure: Marinella Calle, PhD, CMPP, has disclosed no relevant financial relationships.

Content Reviewer

  • Nafeez Zawahir, MD

    Associate CME Clinical Director

    Disclosures

    Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Identifying Patients With Progressive Fibrosing Interstitial Lung Diseases

Authors: Athol Wells, MD; Christopher P. Denton, PhD, FRCPFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CPD Released: 11/19/2018

Valid for credit through: 11/19/2019, 11:59 PM EST

processing....

Educational Impact Challenge

The goal of this activity is to improve physician knowledge regarding the identification of patients with a progressive fibrosing phenotype and potential therapeutic options, including antifibrotic treatment, for patients with progressive fibrosing interstitial lung diseases (PF-ILDs).

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print